Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/17/2023
CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
3/17/2023
CDE Issues the Technical Guidelines for Clinical Trial of Compound Che...
3/17/2023
CDE Issues the Guidelines for Safety Information Summary, Analysis and...
3/17/2023
CDE Issues the FAQs for Rapid Reporting of Safety Data During Drug Cli...
3/17/2023
CDE Issues the Technical Guidelines for Abuse Prevention Pharmaceutica...
3/17/2023
Recent Executive Moves
3/17/2023
Jinyao Pharma Fined CNY 28M for Abuse of Market Dominance to Sell Chem...
3/17/2023
Drug R&D and Product Registration News Digest March 2023 (3)
3/17/2023
Upgrading Medtech Commercial Operations in China (McKinsey)
3/16/2023
China Biotech Fundraising Up Sharply in February as Six Drugmakers Iss...
3/16/2023
ArkBio and Calibr Collaborate on Potential First-in-class Drug for Res...
3/16/2023
Ahead of Pfizer Takeover, Seagen Quietly Sign Deal for Certain Cell Th...
3/15/2023
Deloitte: 2023 China LSHC Investment and M&A Market Outlook
3/15/2023
CDE Issues the List of Reference Formulations for GQCE Studies (66th B...
3/15/2023
NHSA Issues the Interim Measures for the Regulation of Unannounced Ins...
3/15/2023
Two Senior Health Officials under Investigation for Corruption
3/15/2023
NBTRC Statistical Report of Primary Brain Tumors Diagnosed in China in...
3/14/2023
HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside C...
3/14/2023
CDE Issues the List of Reference Formulations for GQCE Studies (65th B...
3/14/2023
CDE Issues the Technical Guidelines for Applicability of Single-Arm Cl...
3/14/2023
CDE Issues the Technical Guidelines for Endpoints in Advanced Prostate...
3/14/2023
CDE Solicits Comments on Two Technical Guidelines for Liposome Drugs
3/14/2023
Study: Alzheimer's Disease Awareness and Acceptance Is Low in China
3/13/2023
Chinese Biotech Startups Rush to Distance Themselves from SVB Collapse
3/13/2023
Frontiers of CGT in China (Simon Kucher)
3/10/2023
Henlius Swallows Bitter Pill in Watered-Down Licensing Deal (Bamboo Wo...
3/10/2023
Onconic Therapeutics Licenses Out GERD Drug Candidate to Livzon for $1...
3/10/2023
Pasteur Institute Severs Ties with Chinese CAS over Joint Institute in...
3/10/2023
Drug R&D and Product Registration News Digest March 2023 (2)
3/10/2023
Recent Executive Moves
Page:
53
/
719
Total number of articles:
21546
:
[First]
[<<]
[51]
[52]
[53]
[54]
[55]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit